1h Free Analyst Time
The global atopic dermatitis drugs market is forecasted to grow by USD 8.35 billion during 2025-2030, accelerating at a CAGR of 11.9% during the forecast period. The report on the global atopic dermatitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic dermatitis, breakthroughs in biologic therapies, favorable reimbursement and insurance.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global atopic dermatitis drugs market is segmented as below:
By Route Of Administration
- Oral
- Topical
- Injectable
By Drug Class
- Biologics
- PDE4 inhibitors
- Corticosteroids
- Calcineurin inhibitors
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global atopic dermatitis drugs market covers the following areas:
- Global atopic dermatitis drugs market sizing
- Global atopic dermatitis drugs market forecast
- Global atopic dermatitis drugs market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Atopic Dermatitis Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Atopic Dermatitis Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
- Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Atopic Dermatitis Drugs Market
6.2 Impact of geopolitical conflicts on Global Atopic Dermatitis Drugs Market
6.2 Impact of geopolitical conflicts on Global Atopic Dermatitis Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Route of Administration
8.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Topical - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical - Market size and forecast 2025-2030 ($ million)
- Chart on Topical - Year-over-year growth 2025-2030 (%)
- Data Table on Topical - Year-over-year growth 2025-2030 (%)
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Biologics - Market size and forecast 2025-2030 ($ million)
- Data Table on Biologics - Market size and forecast 2025-2030 ($ million)
- Chart on Biologics - Year-over-year growth 2025-2030 (%)
- Data Table on Biologics - Year-over-year growth 2025-2030 (%)
- Chart on PDE4 inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on PDE4 inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on PDE4 inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on PDE4 inhibitors - Year-over-year growth 2025-2030 (%)
- Chart on Corticosteroids - Market size and forecast 2025-2030 ($ million)
- Data Table on Corticosteroids - Market size and forecast 2025-2030 ($ million)
- Chart on Corticosteroids - Year-over-year growth 2025-2030 (%)
- Data Table on Corticosteroids - Year-over-year growth 2025-2030 (%)
- Chart on Calcineurin inhibitors - Market size and forecast 2025-2030 ($ million)
- Data Table on Calcineurin inhibitors - Market size and forecast 2025-2030 ($ million)
- Chart on Calcineurin inhibitors - Year-over-year growth 2025-2030 (%)
- Data Table on Calcineurin inhibitors - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
10 Market Segmentation by Distribution Channel
10.1 Market segments
- Chart on Distribution Channel - Market share 2025-2030 (%)
- Data Table on Distribution Channel - Market share 2025-2030 (%)
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
- Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
- Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ million)
- Data Table on Israel - Market size and forecast 2025-2030 ($ million)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising prevalence of chronic dermatitis
- Breakthroughs in biologic therapies
- Favorable reimbursement and insurance
- High treatment costs and reimbursement barriers
- Stringent regulatory frameworks and compliance
- Safety concerns and adverse effects
- Impact of drivers and challenges in 2025 and 2030
- Rise of oral targeted molecules
- Expansion of pediatric treatment indications
- Integration of digital health solutions
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Almirall SA - Overview
- Almirall SA - Business segments
- Almirall SA - Key offerings
- Almirall SA - Segment focus
- SWOT
- Bausch Health Co Inc. - Overview
- Bausch Health Co Inc. - Business segments
- Bausch Health Co Inc. - Key offerings
- Bausch Health Co Inc. - Segment focus
- SWOT
- Chugai Pharmaceutical Co. Ltd. - Overview
- Chugai Pharmaceutical Co. Ltd. - Product / Service
- Chugai Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
- SWOT
- Galderma Group AG - Overview
- Galderma Group AG - Business segments
- Galderma Group AG - Key offerings
- Galderma Group AG - Segment focus
- SWOT
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
- Incyte Corp. - Overview
- Incyte Corp. - Product / Service
- Incyte Corp. - Key news
- Incyte Corp. - Key offerings
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Kyowa Kirin Co. Ltd. - Overview
- Kyowa Kirin Co. Ltd. - Business segments
- Kyowa Kirin Co. Ltd. - Key offerings
- Kyowa Kirin Co. Ltd. - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- SHIONOGI Co. Ltd. - Overview
- SHIONOGI Co. Ltd. - Product / Service
- SHIONOGI Co. Ltd. - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Atopic Dermatitis Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Route of Administration ($ million)
Exhibit 55: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 56: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 57: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Drug Class
Exhibit 59: Data Table on Comparison by Drug Class
Exhibit 60: Chart on Biologics - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Biologics - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Biologics - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Biologics - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on PDE4 inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on PDE4 inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on PDE4 inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on PDE4 inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Corticosteroids - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Corticosteroids - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Calcineurin inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Calcineurin inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Calcineurin inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Calcineurin inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Drug Class ($ million)
Exhibit 77: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 78: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 79: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by Distribution Channel
Exhibit 81: Data Table on Comparison by Distribution Channel
Exhibit 82: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Distribution Channel ($ million)
Exhibit 95: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: AbbVie Inc. - Overview
Exhibit 227: AbbVie Inc. - Business segments
Exhibit 228: AbbVie Inc. - Key news
Exhibit 229: AbbVie Inc. - Key offerings
Exhibit 230: AbbVie Inc. - Segment focus
Exhibit 231: SWOT
Exhibit 232: Almirall SA - Overview
Exhibit 233: Almirall SA - Business segments
Exhibit 234: Almirall SA - Key offerings
Exhibit 235: Almirall SA - Segment focus
Exhibit 236: SWOT
Exhibit 237: Bausch Health Co Inc. - Overview
Exhibit 238: Bausch Health Co Inc. - Business segments
Exhibit 239: Bausch Health Co Inc. - Key offerings
Exhibit 240: Bausch Health Co Inc. - Segment focus
Exhibit 241: SWOT
Exhibit 242: Chugai Pharmaceutical Co. Ltd. - Overview
Exhibit 243: Chugai Pharmaceutical Co. Ltd. - Product / Service
Exhibit 244: Chugai Pharmaceutical Co. Ltd. - Key offerings
Exhibit 245: SWOT
Exhibit 246: Eli Lilly and Co. - Overview
Exhibit 247: Eli Lilly and Co. - Product / Service
Exhibit 248: Eli Lilly and Co. - Key news
Exhibit 249: Eli Lilly and Co. - Key offerings
Exhibit 250: SWOT
Exhibit 251: Galderma Group AG - Overview
Exhibit 252: Galderma Group AG - Business segments
Exhibit 253: Galderma Group AG - Key offerings
Exhibit 254: Galderma Group AG - Segment focus
Exhibit 255: SWOT
Exhibit 256: GlaxoSmithKline Plc - Overview
Exhibit 257: GlaxoSmithKline Plc - Business segments
Exhibit 258: GlaxoSmithKline Plc - Key news
Exhibit 259: GlaxoSmithKline Plc - Key offerings
Exhibit 260: GlaxoSmithKline Plc - Segment focus
Exhibit 261: SWOT
Exhibit 262: Incyte Corp. - Overview
Exhibit 263: Incyte Corp. - Product / Service
Exhibit 264: Incyte Corp. - Key news
Exhibit 265: Incyte Corp. - Key offerings
Exhibit 266: SWOT
Exhibit 267: Johnson and Johnson - Overview
Exhibit 268: Johnson and Johnson - Business segments
Exhibit 269: Johnson and Johnson - Key news
Exhibit 270: Johnson and Johnson - Key offerings
Exhibit 271: Johnson and Johnson - Segment focus
Exhibit 272: SWOT
Exhibit 273: Kyowa Kirin Co. Ltd. - Overview
Exhibit 274: Kyowa Kirin Co. Ltd. - Business segments
Exhibit 275: Kyowa Kirin Co. Ltd. - Key offerings
Exhibit 276: Kyowa Kirin Co. Ltd. - Segment focus
Exhibit 277: SWOT
Exhibit 278: Pfizer Inc. - Overview
Exhibit 279: Pfizer Inc. - Business segments
Exhibit 280: Pfizer Inc. - Key news
Exhibit 281: Pfizer Inc. - Key offerings
Exhibit 282: Pfizer Inc. - Segment focus
Exhibit 283: SWOT
Exhibit 284: Sanofi SA - Overview
Exhibit 285: Sanofi SA - Business segments
Exhibit 286: Sanofi SA - Key news
Exhibit 287: Sanofi SA - Key offerings
Exhibit 288: Sanofi SA - Segment focus
Exhibit 289: SWOT
Exhibit 290: SHIONOGI Co. Ltd. - Overview
Exhibit 291: SHIONOGI Co. Ltd. - Product / Service
Exhibit 292: SHIONOGI Co. Ltd. - Key offerings
Exhibit 293: SWOT
Exhibit 294: Teva Pharmaceutical Ltd. - Overview
Exhibit 295: Teva Pharmaceutical Ltd. - Business segments
Exhibit 296: Teva Pharmaceutical Ltd. - Key news
Exhibit 297: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 298: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Viatris Inc. - Overview
Exhibit 301: Viatris Inc. - Business segments
Exhibit 302: Viatris Inc. - Key news
Exhibit 303: Viatris Inc. - Key offerings
Exhibit 304: Viatris Inc. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Inclusions checklist
Exhibit 307: Exclusions checklist
Exhibit 308: Currency conversion rates for US$
Exhibit 309: Research methodology
Exhibit 310: Information sources
Exhibit 311: Data validation
Exhibit 312: Validation techniques employed for market sizing
Exhibit 313: Data synthesis
Exhibit 314: 360 degree market analysis
Exhibit 315: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 7: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Atopic Dermatitis Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Drug Class Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 39: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Route of Administration
Exhibit 41: Data Table on Comparison by Route of Administration
Exhibit 42: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Route of Administration ($ million)
Exhibit 55: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 56: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 57: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Drug Class
Exhibit 59: Data Table on Comparison by Drug Class
Exhibit 60: Chart on Biologics - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Biologics - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Biologics - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Biologics - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on PDE4 inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on PDE4 inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on PDE4 inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on PDE4 inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Corticosteroids - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Corticosteroids - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Calcineurin inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Calcineurin inhibitors - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Calcineurin inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Calcineurin inhibitors - Year-over-year growth 2025-2030 (%)
Exhibit 76: Market opportunity by Drug Class ($ million)
Exhibit 77: Data Table on Market opportunity by Drug Class ($ million)
Exhibit 78: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 79: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 80: Chart on Comparison by Distribution Channel
Exhibit 81: Data Table on Comparison by Distribution Channel
Exhibit 82: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 94: Market opportunity by Distribution Channel ($ million)
Exhibit 95: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 97: Chart on Market share by geography 2025-2030 (%)
Exhibit 98: Data Table on Market share by geography 2025-2030 (%)
Exhibit 99: Chart on Geographic comparison
Exhibit 100: Data Table on Geographic comparison
Exhibit 101: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 102: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 104: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 105: Chart on Regional Comparison - North America
Exhibit 106: Data Table on Regional Comparison - North America
Exhibit 107: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 108: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 109: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Regional Comparison - Europe
Exhibit 124: Data Table on Regional Comparison - Europe
Exhibit 125: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 126: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 127: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Regional Comparison - Asia
Exhibit 154: Data Table on Regional Comparison - Asia
Exhibit 155: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 156: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 157: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 160: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 161: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 184: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 185: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 186: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 187: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Israel - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 217: Market opportunity by geography ($ million)
Exhibit 218: Data Tables on Market opportunity by geography ($ million)
Exhibit 219: Impact of drivers and challenges in 2025 and 2030
Exhibit 220: Overview on criticality of inputs and factors of differentiation
Exhibit 221: Overview on factors of disruption
Exhibit 222: Impact of key risks on business
Exhibit 223: Companies covered
Exhibit 224: Company ranking index
Exhibit 225: Matrix on companies position and classification
Exhibit 226: AbbVie Inc. - Overview
Exhibit 227: AbbVie Inc. - Business segments
Exhibit 228: AbbVie Inc. - Key news
Exhibit 229: AbbVie Inc. - Key offerings
Exhibit 230: AbbVie Inc. - Segment focus
Exhibit 231: SWOT
Exhibit 232: Almirall SA - Overview
Exhibit 233: Almirall SA - Business segments
Exhibit 234: Almirall SA - Key offerings
Exhibit 235: Almirall SA - Segment focus
Exhibit 236: SWOT
Exhibit 237: Bausch Health Co Inc. - Overview
Exhibit 238: Bausch Health Co Inc. - Business segments
Exhibit 239: Bausch Health Co Inc. - Key offerings
Exhibit 240: Bausch Health Co Inc. - Segment focus
Exhibit 241: SWOT
Exhibit 242: Chugai Pharmaceutical Co. Ltd. - Overview
Exhibit 243: Chugai Pharmaceutical Co. Ltd. - Product / Service
Exhibit 244: Chugai Pharmaceutical Co. Ltd. - Key offerings
Exhibit 245: SWOT
Exhibit 246: Eli Lilly and Co. - Overview
Exhibit 247: Eli Lilly and Co. - Product / Service
Exhibit 248: Eli Lilly and Co. - Key news
Exhibit 249: Eli Lilly and Co. - Key offerings
Exhibit 250: SWOT
Exhibit 251: Galderma Group AG - Overview
Exhibit 252: Galderma Group AG - Business segments
Exhibit 253: Galderma Group AG - Key offerings
Exhibit 254: Galderma Group AG - Segment focus
Exhibit 255: SWOT
Exhibit 256: GlaxoSmithKline Plc - Overview
Exhibit 257: GlaxoSmithKline Plc - Business segments
Exhibit 258: GlaxoSmithKline Plc - Key news
Exhibit 259: GlaxoSmithKline Plc - Key offerings
Exhibit 260: GlaxoSmithKline Plc - Segment focus
Exhibit 261: SWOT
Exhibit 262: Incyte Corp. - Overview
Exhibit 263: Incyte Corp. - Product / Service
Exhibit 264: Incyte Corp. - Key news
Exhibit 265: Incyte Corp. - Key offerings
Exhibit 266: SWOT
Exhibit 267: Johnson and Johnson - Overview
Exhibit 268: Johnson and Johnson - Business segments
Exhibit 269: Johnson and Johnson - Key news
Exhibit 270: Johnson and Johnson - Key offerings
Exhibit 271: Johnson and Johnson - Segment focus
Exhibit 272: SWOT
Exhibit 273: Kyowa Kirin Co. Ltd. - Overview
Exhibit 274: Kyowa Kirin Co. Ltd. - Business segments
Exhibit 275: Kyowa Kirin Co. Ltd. - Key offerings
Exhibit 276: Kyowa Kirin Co. Ltd. - Segment focus
Exhibit 277: SWOT
Exhibit 278: Pfizer Inc. - Overview
Exhibit 279: Pfizer Inc. - Business segments
Exhibit 280: Pfizer Inc. - Key news
Exhibit 281: Pfizer Inc. - Key offerings
Exhibit 282: Pfizer Inc. - Segment focus
Exhibit 283: SWOT
Exhibit 284: Sanofi SA - Overview
Exhibit 285: Sanofi SA - Business segments
Exhibit 286: Sanofi SA - Key news
Exhibit 287: Sanofi SA - Key offerings
Exhibit 288: Sanofi SA - Segment focus
Exhibit 289: SWOT
Exhibit 290: SHIONOGI Co. Ltd. - Overview
Exhibit 291: SHIONOGI Co. Ltd. - Product / Service
Exhibit 292: SHIONOGI Co. Ltd. - Key offerings
Exhibit 293: SWOT
Exhibit 294: Teva Pharmaceutical Ltd. - Overview
Exhibit 295: Teva Pharmaceutical Ltd. - Business segments
Exhibit 296: Teva Pharmaceutical Ltd. - Key news
Exhibit 297: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 298: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 299: SWOT
Exhibit 300: Viatris Inc. - Overview
Exhibit 301: Viatris Inc. - Business segments
Exhibit 302: Viatris Inc. - Key news
Exhibit 303: Viatris Inc. - Key offerings
Exhibit 304: Viatris Inc. - Segment focus
Exhibit 305: SWOT
Exhibit 306: Inclusions checklist
Exhibit 307: Exclusions checklist
Exhibit 308: Currency conversion rates for US$
Exhibit 309: Research methodology
Exhibit 310: Information sources
Exhibit 311: Data validation
Exhibit 312: Validation techniques employed for market sizing
Exhibit 313: Data synthesis
Exhibit 314: 360 degree market analysis
Exhibit 315: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Almirall SA
- Arcutis Biotherapeutics Inc.
- Bausch Health Co Inc.
- Chugai Pharmaceutical Co. Ltd.
- Eli Lilly and Co.
- Galderma Group AG
- GlaxoSmithKline Plc
- Incyte Corp.
- Johnson and Johnson
- Kyowa Kirin Co. Ltd.
- LEO Pharma AS
- Maruho Co. Ltd.
- Organon and Co.
- Otsuka Pharmaceutical Co Ltd.
- Pfizer Inc.
- Sanofi SA
- SHIONOGI Co. Ltd.
- Teva Pharmaceutical Ltd.
- Viatris Inc.
